Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRecord Regulatory News (REC)

Share Price Information for Record (REC)

Share Price is delayed by 15 minutes
Get Live Data
54.00    -0.20 (-0.37%)
Bid:
54.00
Ask:
55.00
Spread: 1.00 (1.852%)
Market Cap: £104.31m
REC Live PriceLast checked at - London Stock Exchange

Intraday Record Share Chart

Directorate Change

25 Jun 2024 15:20

RNS Number : 8219T
Record PLC
25 June 2024
 

 

The information contained within this announcement constituteS inside information as defined by the Market Abuse Regulations (EU) No. 596/2014, which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018 ("UK MAR"). Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

25 June 2024

 

RECORD PLC

 

Board Changes

 

Record plc ("Record", the "Company" or the "Group"), the specialist currency and asset manager, announces the following changes to its board of directors (the ''Board'').

 

 

Resignation of Tim Edwards

Having completed his second three-year term, Tim Ewards has decided not to continue for a third term, in order to focus on his activities in the biotechnology sector and will be stepping down from the Board and his role as Senior Independent Director, effective today.

Krystyna Nowak will become Senior Independent Director and Chair of the Remuneration Committee.

Tim Edwards, outgoing Senior Independent Director said: "It is pleasing to see the company's Succession Plan now in place and I send best wishes to Jan, Richard and Kevin, and my Board colleagues, for the next chapter in the development of the new opportunities for this business."

Appointment of New Non-Executive Director

Dr. Othman Boukrami will join the Board with effect from 1 July 2024 and will also become a member of the Audit, Remuneration and Nomination Committees. Othman is currently Chief Investment Officer of TCX, The Currency Exchange Fund, having earlier in his career held senior positions in the African Development Group and Citibank. Othman brings highly pertinent sector expertise to the Board.

Appointment of Kevin Ayles

Kevin Ayles will join the Board with effect from 1 July 2024. Kevin has been a valuable member of the senior leadership team since joining Record in 2007 and currently serves as Group Head of HR, Director of Record Currency Management Limited, and as Company Secretary of Record plc. Kevin possesses extensive knowledge of the business and its key stakeholders and his involvement in major strategic initiatives makes it a natural next step for him to join the Board and continue contributing to the organisation's success.

David Morrison, Chairman of Record plc, said, "I am pleased that we continue to strengthen the leadership of the business by attracting high-calibre candidates to our Board and by recognising the importance of our senior leaders. I would like to thank Tim for the commitment and time he has brought to his role whilst on the Board and I wish him all the best in his future endeavours. I am also pleased to welcome both Othman Boukrami and Kevin Ayles to the Board. Othman is a highly knowledgeable professional, specifically in the field of emerging market and frontier currencies. Kevin has been an indispensable member of the senior leadership team during a period of rapid expansion and change."

This announcement is made pursuant to Listing Rule 9.6.11R.

The Company confirms that no further disclosure is required under LR 9.6.13R in respect of the appointment of Kevin Ayles as an executive director and Dr. Othman Boukrami as a non-executive director of the Company.

Kevin Ayles has interests in 1,042,341 Ordinary Shares in the Company.

For further information, please contact:

 

Record plc +44 (0) 1753 852222

David Morrison - Chairman

Dr Jan Witte - Chief Executive Officer

 

 

Buchanan +44 (0) 20 7466 5000

Simon Compton

Henry Wilson record@buchanan.uk.com

George Beale

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUBGQUPCGCA
Date   Source Headline
1st Jun 20263:56 pmRNSDirector/PDMR Shareholding
28th Apr 20264:49 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSRECORD PLC FOURTH QUARTER TRADING UPDATE (Q4 FY26)
15th Apr 202610:38 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNS-RSwiss pension fund partnership invests in NorthC
10th Mar 20262:00 pmRNSDirectorate change
4th Mar 20265:31 pmRNSDirector/PDMR Shareholding
28th Jan 20264:46 pmRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSThird Quarter Trading Update
31st Dec 202511:57 amRNSDirector/PDMR Shareholding
24th Dec 20259:23 amRNSDirector/PDMR Shareholding
24th Dec 20259:23 amRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSDirectorate change
2nd Dec 20255:26 pmRNSDirector/PDMR Shareholding
20th Nov 20258:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSHalf-year Financial Report
6th Nov 202511:32 amRNS-RInvestor Presentation via Investor Meet Company
29th Oct 202512:58 pmRNSDirector/PDMR Shareholding
24th Oct 20257:00 amRNSSecond Quarter Trading Update
14th Oct 202512:11 pmRNSDirectorate Change & Senior Subsidiary Appointment
10th Oct 20257:00 amRNSHolding(s) in Company
1st Oct 20253:40 pmRNSDirector/PDMR Shareholding
2nd Sep 20255:12 pmRNSDirector/PDMR Shareholding
11th Aug 20251:55 pmRNSDirector/PDMR Shareholding
31st Jul 20251:22 pmRNSDirector/PDMR Shareholding
31st Jul 20251:13 pmRNSDirector/PDMR Shareholding
25th Jul 20257:00 amRNSFirst Quarter Trading Update
24th Jul 20257:00 amRNSResult of AGM
4th Jul 202511:20 amRNSDirector/PDMR Shareholding
1st Jul 20254:29 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNS-RPublication of Sustainability & Climate Reports
25th Jun 202511:25 amRNSDirector/PDMR Shareholding
25th Jun 202511:23 amRNSDirector/PDMR Shareholding
24th Jun 20253:11 pmRNSNotice of AGM and Dividend Timetable
20th Jun 20259:00 amRNS-RInvestor presentation via Investor Meet Company
20th Jun 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNS-RNon-Binding Term Sheets for US$2.2 billion signed
29th May 202510:58 amRNSDirector/PDMR Shareholding
28th May 202512:21 pmRNSHolding(s) in Company
1st May 20252:21 pmRNSDirector/PDMR Shareholding
25th Apr 20257:00 amRNSFourth Quarter Trading Update
31st Mar 20252:21 pmRNSDirector/PDMR Shareholding
18th Mar 20259:20 amRNS-RAPPOINTMENT OF ANDREAS DÄNZER AS GROUP CIO
28th Feb 20253:31 pmRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSThird Quarter Trading Update
31st Dec 20247:00 amRNSDirector/PDMR Shareholding
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
19th Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.